FOLD and EDIT are in the spotlight following patent dispute settlement news and strategic updates, respectively.

The global cryoglobulinemia treatment market is poised for significant growth, with an expected market value of US$ 496 ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its third quarter 2024 financial and ...

Teva Pharmaceuticals USA Inc. (Teva USA) and Teva Neuroscience Inc. (“Teva”) agreed to pay $450 million to resolve two matters that allege ...